================================================================================
EMBEDDING MODEL COMPARISON REPORT
================================================================================

MiniLM Model: all-MiniLM-L6-v2
BioBERT Model: dmis-lab/biobert-base-cased-v1.1

================================================================================


LUNG CANCER
--------------------------------------------------------------------------------

  Patient Case 1:
    MiniLM - Avg Score: 0.6561, Top Score: 0.6688
    BioBERT - Avg Score: 0.9305, Top Score: 0.9359
    Difference: +0.2744 (avg), +0.2670 (top)
    ✓ BioBERT performs better
    MiniLM Top Trial: A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Lo
    BioBERT Top Trial: COr Loco-regional Advanced Lung Cancer Treated With Chemo-radiotherapy (COLA)

  Patient Case 2:
    MiniLM - Avg Score: 0.5977, Top Score: 0.6560
    BioBERT - Avg Score: 0.9306, Top Score: 0.9332
    Difference: +0.3329 (avg), +0.2772 (top)
    ✓ BioBERT performs better
    MiniLM Top Trial: Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable L
    BioBERT Top Trial: Evaluation of Prognostic Factors: From Breast Cancer to Bone Metastases

GLIOBLASTOMA
--------------------------------------------------------------------------------

  Patient Case 1:
    MiniLM - Avg Score: 0.6990, Top Score: 0.7310
    BioBERT - Avg Score: 0.9423, Top Score: 0.9461
    Difference: +0.2433 (avg), +0.2150 (top)
    ✓ BioBERT performs better
    MiniLM Top Trial: Hypofractionated Stereotactic Radiotherapy in Recurrent Glioblastoma Multiforme
    BioBERT Top Trial: Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

  Patient Case 2:
    MiniLM - Avg Score: 0.7082, Top Score: 0.7139
    BioBERT - Avg Score: 0.9485, Top Score: 0.9516
    Difference: +0.2404 (avg), +0.2377 (top)
    ✓ BioBERT performs better
    MiniLM Top Trial: Evaluation of Maximum Tolerated Dose, Safety and Efficiency of MSC11FCD Therapy to Recurrent Gliobla
    BioBERT Top Trial: Glioblastoma Response Prediction to Apatinib

TYPE 2 DIABETES
--------------------------------------------------------------------------------

  Patient Case 1:
    MiniLM - Avg Score: 0.6957, Top Score: 0.7422
    BioBERT - Avg Score: 0.9442, Top Score: 0.9458
    Difference: +0.2485 (avg), +0.2036 (top)
    ✓ BioBERT performs better
    MiniLM Top Trial: Mechanisms of Fatigability With Diabetes
    BioBERT Top Trial: The eHealth Diabetes Remission Trial

  Patient Case 2:
    MiniLM - Avg Score: 0.6576, Top Score: 0.7066
    BioBERT - Avg Score: 0.9425, Top Score: 0.9437
    Difference: +0.2850 (avg), +0.2371 (top)
    ✓ BioBERT performs better
    MiniLM Top Trial: Effect of Treatment With Metformin in Type 2 Diabetes Patients on Alternative Genes Splicing
    BioBERT Top Trial: Sleeve Gastrectomy and Roux-en-Y Gastric Bypass in the Treatment of Type 2 Diabetes Mellitus.

================================================================================
OVERALL SUMMARY
================================================================================

Average Match Score Across All Cases:
  MiniLM:  0.6690
  BioBERT: 0.9398
  Difference: +0.2708

✓ RECOMMENDATION: Use BioBERT (better average match scores)

================================================================================